286
Views
12
CrossRef citations to date
0
Altmetric
Drug Profile

Cladribine tablets: a potential new short-course annual treatment for relapsing multiple sclerosis

Pages 365-375 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Giancarlo Comi, Hans-Peter Hartung, Nuwan C Kurukulasuriya, Steven J Greenberg & Matthew Scaramozza. (2013) Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis. Expert Opinion on Pharmacotherapy 14:1, pages 123-136.
Read now
Julie A Murphy, Jacklyn A Harris & Andrew J Crannage. (2010) Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric Disease and Treatment 6, pages 619-625.
Read now
Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, Olaf Stüve & Bernd C Kieseier. (2010) Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine. Drug Design, Development and Therapy 4, pages 117-126.
Read now

Articles from other publishers (9)

Ibrahim M Dighriri, Ahood A Aldalbahi, Fatimah Albeladi, Asimah A Tahiri, Elaf M Kinani, Rand A Almohsen, Nouf H Alamoudi, Abeer A Alanazi, Sultan J Alkhamshi, Noha A Althomali, Sultan N Alrubaiei & Faisal K Altowairqi. (2023) An Overview of the History, Pathophysiology, and Pharmacological Interventions of Multiple Sclerosis. Cureus.
Crossref
Galal H. Elgemeie & Reham A. Mohamed-Ezzat. 2022. New Strategies Targeting Cancer Metabolism. New Strategies Targeting Cancer Metabolism 69 105 .
Veronica Tsin Fong Voo, Helmut Butzkueven, Jim Stankovich, Terence O'Brien & Mastura Monif. (2021) The development and impact of cladribine on lymphoid and myeloid cells in multiple sclerosis. Multiple Sclerosis and Related Disorders 52, pages 102962.
Crossref
L Ø Jørgensen, K H Hyrlov, M L Elkjaer, A B Weber, A E Pedersen, Å Fex Svenningsen & Z Illes. (2020) Cladribine modifies functional properties of microglia. Clinical and Experimental Immunology 201:3, pages 328-340.
Crossref
Gavin Giovannoni. (2017) Cladribine to Treat Relapsing Forms of Multiple Sclerosis. Neurotherapeutics 14:4, pages 874-887.
Crossref
Eric M. Williamson & Joseph R. Berger. (2015) Infection Risk in Patients on Multiple Sclerosis Therapeutics. CNS Drugs 29:3, pages 229-244.
Crossref
Gavin Giovannoni & Stuart D. Cook. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 358 369 .
. 2011. Multiple Sclerosis Therapeutics. Multiple Sclerosis Therapeutics 300 582 .
Thomas P. Leist & Robert Weissert. (2011) Cladribine. Clinical Neuropharmacology 34:1, pages 28-35.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.